Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuronal Nicotinic Receptor Modulation in the Treatment of Autism: A Pilot Trial of Mecamylamine

NCT00773812 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT00773812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00773812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuronal Nicotinic Receptor Modulation in the Treatment of Autism: A Pilot Trial of Mecamylamine
Lead sponsor
Ohio State University
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2007
Completion date
November 30, 2012
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autistic disorder, pervasive developmental disorder